Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15
Original Research
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,885 | Dovepress* | 6,998+ | 665 | 7,663 | |
| PubMed Central* | 887 | 278 | 1,165 | ||
| Totals | 7,885 | 943 | 8,828 | ||
| *Since 3 December 2020 | |||||
View citations on PubMed Central and Google Scholar